Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...

The industry wants the ability to make bolder health claims and to get the government and private insurers to pay for its products — as they do FDA-approved drugs.

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.The commercialization was ...

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

The affected products were primarily distributed to long-term care facilities and were not available for retail sale ...

Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...